- Home
- ARCT vs BHK Comparison
ARCT vs BHK Comparison
Compare ARCT & BHK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARCT | BHK |
|---|---|---|
| Founded | 2013 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 189.9M | 654.4M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | ARCT | BHK |
|---|---|---|
| Price | $7.04 | $9.05 |
| Analyst Decision | Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $27.70 | N/A |
| AVG Volume (30 Days) | ★ 463.0K | 318.0K |
| Earning Date | 03-03-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.34% |
| EPS Growth | ★ 20.00 | N/A |
| EPS | N/A | ★ 1.03 |
| Revenue | ★ $82,031,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $8.84 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.85 | $9.01 |
| 52 Week High | $24.14 | $11.00 |
Technical Indicators
Market Signals| Indicator | ARCT | BHK |
|---|---|---|
| Relative Strength Index (RSI) | 48.18 | 31.47 |
| Support Level | $6.90 | $9.03 |
| Resistance Level | $7.88 | $9.72 |
| Average True Range (ATR) | 0.35 | 0.08 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 45.88 | 9.09 |
Price Performance
Historical ComparisonAbout ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.
About BHK Blackrock Core Bond Trust
Blackrock Core Bond Trust is a closed-ended management investment company. Its objective is to provide current income and capital appreciation. The trust seeks to achieve its investment objective by investing, under normal market conditions, at least 75% of its managed assets in bonds that are investment-grade quality at the time of investment. The trust, under a normal market scenario, will invest in a range of bonds, including corporate bonds, U.S. government and agency securities, and mortgage-related securities.